These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 18349088)
21. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578 [TBL] [Abstract][Full Text] [Related]
22. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811 [TBL] [Abstract][Full Text] [Related]
23. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192). Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822 [TBL] [Abstract][Full Text] [Related]
24. Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Radić Antolić M; Beriša M; Rumora L J Clin Pathol; 2018 Nov; 71(11):963-970. PubMed ID: 29858231 [TBL] [Abstract][Full Text] [Related]
25. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Haj Mouhamed D; Ezzaher A; Mechri A; Neffati F; Omezzine A; Bouslama A; Gaha L; Douki W; Najjar MF Environ Health Prev Med; 2012 Jul; 17(4):316-21. PubMed ID: 22205545 [TBL] [Abstract][Full Text] [Related]
33. Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners? Davis KA; Crow JA; Chambers HW; Meek EC; Chambers JE Environ Health Perspect; 2009 Aug; 117(8):1226-31. PubMed ID: 19672401 [TBL] [Abstract][Full Text] [Related]
34. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease. Kennedy DJ; Tang WH; Fan Y; Wu Y; Mann S; Pepoy M; Hazen SL J Am Heart Assoc; 2013 Apr; 2(2):e000104. PubMed ID: 23557751 [TBL] [Abstract][Full Text] [Related]
35. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130 [TBL] [Abstract][Full Text] [Related]
36. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients. Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255 [TBL] [Abstract][Full Text] [Related]
37. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314 [TBL] [Abstract][Full Text] [Related]
39. Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score. Souza-Nogueira A; Camargo AE; Remondi FA; Paoliello MM; Richter RJ; Furlong CE; Barbosa DS; Maes M; Moreira EG Arch Endocrinol Metab; 2016 Oct; 60(5):426-435. PubMed ID: 27812605 [TBL] [Abstract][Full Text] [Related]
40. The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes. Zargari M; Sharafeddin F; Mahrooz A; Alizadeh A; Masoumi P Exp Biol Med (Maywood); 2016 Aug; 241(14):1489-96. PubMed ID: 27022137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]